Press Releases about Cymabay Therapeutics
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
From Brodsky & Smith LLC
Via GlobeNewswire
CymaBay Therapeutics Inc. (NASDAQ: CBAY) is a Stock Spotlight on 2/21
February 21, 2024
![](https://mms.businesswire.com/media/20240216171507/en/1919461/22/Latest_KSF_M%26A.jpg)
CymaBay Therapeutics Inc. (NASDAQ: CBAY) is a Stock Spotlight on 2/13
February 13, 2024
![](https://www.marketbeat.com/logos/articles/med_20240214075553_analysts-see-over-50-gains-in-these-2-mid-cap-biot.jpg)
Analysts see over 50% gains in these 2 mid-cap biotech stocks
February 14, 2024
Via MarketBeat
Topics
Artificial Intelligence
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
From Brodsky & Smith LLC
Via GlobeNewswire
![](https://mms.businesswire.com/media/20240212315716/en/1567526/5/Firm_Logo-with_Investor_Law_Firm.jpg)
![](https://mms.businesswire.com/media/20240211034242/en/2030601/5/Logo_CymaBay-Therapeutics-Oct18-rgb-color.jpg)
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.